Lifeward (LFWD) Liabilities and Shareholders Equity (2014 - 2026)

Lifeward (LFWD) reported Liabilities and Shareholders Equity of $33.4 million for Q1 2026, up 16.0% on a YoY basis from $28.8 million in Q1 2025, and up 45.93% sequentially from $22.9 million in Q4 2025.

Lifeward (LFWD) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Lifeward (LFWD) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $33.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 16.0% year-over-year to $33.4 million; the trailing twelve-month figure through Mar 2026 stood at $106.3 million (down 31.9% YoY), and the FY2025 full-year result was $22.9 million, down 24.89% from the prior year.
  • Liabilities and Shareholders Equity rose to $33.4 million in Q1 2026, from $22.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $90.0 million in Q1 2022 to a low of $22.9 million in Q4 2025.
  • A 5-year average of $53.9 million and a median of $55.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity grew 20.7% in 2022 and slumped 51.75% in 2024, its largest moves.
  • Tracing LFWD's Liabilities and Shareholders Equity over 5 years: stood at $74.2 million in 2022, then dropped by 14.88% to $63.2 million in 2023, then sank by 51.75% to $30.5 million in 2024, then decreased by 24.89% to $22.9 million in 2025, then jumped by 45.93% to $33.4 million in 2026.
  • Business Quant data shows LFWD's Liabilities and Shareholders Equity at $33.4 million in Q1 2026, $22.9 million in Q4 2025, and $23.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Lifeward 8.16 Mn -3.26 Mn 1.34 Mn 33.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 33.42 Mn
Dec 31, 2025 22.90 Mn
Sep 30, 2025 23.17 Mn
Jun 30, 2025 26.78 Mn
Mar 31, 2025 28.81 Mn
Dec 31, 2024 30.49 Mn
Sep 30, 2024 45.77 Mn
Jun 30, 2024 50.98 Mn
Mar 31, 2024 55.22 Mn
Dec 31, 2023 63.19 Mn
Sep 30, 2023 69.22 Mn
Jun 30, 2023 65.81 Mn
Mar 31, 2023 68.98 Mn
Dec 31, 2022 74.24 Mn
Sep 30, 2022 80.77 Mn
Jun 30, 2022 85.80 Mn
Mar 31, 2022 90.00 Mn
Dec 31, 2021 94.75 Mn
Sep 30, 2021 98.72 Mn
Jun 30, 2021 71.71 Mn